Cripto blocking antibodies and uses thereof
CA 2715570 A1 · Owner: Biogen Idec Ma Inc. · Inventors: Schiffer, Susan; Sanicola-Nadel, Michele; Williams, Kevin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides Cripto blocking antibodies or biologically functional , fragments thereof, and uses thereof. Antibodies which bind Cripto and modulate Cripto signalling , are provided. Antibodies which bind Cripto and block the interaction between Cripto and , ALK4 are provided. Antibodies which bind Cripto and modulate tumor growth are also , provided. Antibodies which bind Cripto modulate signalling, and modulate , tumor growth are also provided. Antibodies which bind Cripto block the interaction , between , Cripto and ALK4 and modulate tumor growth are provided. The invention also provides , methods of using these antibodies in therapeutic diagnostic, and research , …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 17, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 17, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 17, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.